Simple jQuery Dropdowns

Browsing by Author Pierre Van Damme

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)
1-Jul-2015Immunogenicity and safety of a 9-valent HPV vaccinePierre Van Damme; Sven Eric Olsson; Stanley Block; Xavier Castellsague; Glenda E. Gray; Teobaldo Herrera; Li Min Huang; Dong Soo Kim; Punnee Pitisuttithum; Joshua Chen; Susan Christiano; Roger Maansson; Erin Moeller; Xiao Sun; Scott Vuocolo; Alain Luxembourg; Universiteit Antwerpen; Danderyd Hospital; Kentucky Pediatric Research Institute; Institute Catala Oncologia; University of Witwatersrand; Instituto de Investigation Nutricional; National Taiwan University College of Medicine; Yonsei University College of Medicine; Mahidol University; Merck & Co., Inc.
1-Jun-2017Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine – A combined analysis of five phase III clinical trialsLone K. Petersen; Jaime Restrepo; Edson D. Moreira; Ole Erik Iversen; Punnee Pitisuttithum; Pierre Van Damme; Elmar A. Joura; Sven Erik Olsson; Daron Ferris; Stan Block; Anna R. Giuliano; Xavier Bosch; Sophie Pils; Jack Cuzick; Suzanne M. Garland; Warner Huh; Susanne K. Kjaer; Oliver M. Bautista; Donna Hyatt; Roger Maansson; Erin Moeller; Hong Qi; Christine Roberts; Alain Luxembourg; Ârhus Universitetshospital; Fundación Centro de Investigación Clínica CIC; Fundacao Oswaldo Cruz; Universitetet i Bergen; Mahidol University; Universiteit Antwerpen; Medizinische Universitat Wien; Karolinska Institutet; Augusta University; Kentucky Pediatric and Adult Research Inc; Moffitt Cancer Center; Institute Catala Oncologia; Barts and The London School of Medicine and Dentistry; Murdoch Children's Research Institute; University of Alabama; Kræftens Bekæmpelse; Merck & Co., Inc.